DOCS
Doximity, Inc. NYSE$24.89
Mkt Cap $4.7B
52w Low $20.55
7.8% of range
52w High $76.51
50d MA $24.19
200d MA $47.56
P/E (TTM)
21.0x
EV/EBITDA
44.2x
P/B
4.3x
Debt/Equity
0.0x
ROE
21.4%
P/FCF
40.6x
RSI (14)
—
ATR (14)
—
Beta
1.42
50d MA
$24.19
200d MA
$47.56
Avg Volume
3.7M
About
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily se…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | AMC | 0.44 | 0.46 | +4.5% | 33.32 | -28.9% | -16.8% | -17.5% | -18.2% | -22.1% | -25.8% | — |
| Nov 6, 2025 | AMC | 0.38 | 0.45 | +18.8% | 62.58 | -9.7% | -13.2% | -16.0% | -15.8% | -18.6% | -20.5% | — |
| Aug 7, 2025 | AMC | 0.30 | 0.36 | +19.4% | 58.55 | +7.6% | +13.7% | +5.6% | +5.6% | +9.3% | +8.5% | — |
| May 15, 2025 | AMC | 0.27 | 0.38 | +39.9% | 58.45 | -17.1% | -10.1% | -8.0% | -9.3% | -13.2% | -12.3% | — |
| Feb 6, 2025 | AMC | 0.31 | 0.45 | +45.2% | 58.26 | +24.4% | +36.0% | +42.7% | +28.6% | +29.0% | +32.1% | — |
| Nov 7, 2024 | AMC | 0.25 | 0.30 | +20.0% | 43.42 | +35.6% | +34.2% | +41.1% | +33.7% | +21.7% | +19.9% | — |
| Aug 8, 2024 | AMC | 0.22 | 0.28 | +27.3% | 25.66 | +27.4% | +38.7% | +36.2% | +38.7% | +38.3% | +36.3% | — |
| May 16, 2024 | AMC | 0.20 | 0.25 | +25.0% | 23.74 | +21.4% | +18.1% | +22.0% | +18.6% | +18.1% | +15.5% | — |
| Feb 8, 2024 | AMC | 0.23 | 0.29 | +26.1% | 28.24 | -11.6% | +1.2% | +7.9% | +2.8% | +4.1% | +7.4% | — |
| Nov 9, 2023 | AMC | 0.18 | 0.22 | +22.2% | 20.50 | +19.2% | +16.2% | +16.5% | +23.9% | +23.9% | +23.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 | Truist | Downgrade | Buy → Hold | — | $24.71 | $23.50 | -4.9% | -1.3% | -2.3% | -1.8% | -6.2% | -2.8% |
| Apr 16 | BofA Securities | Maintains | Buy → Buy | — | $23.90 | $24.24 | +1.4% | +1.5% | +3.4% | +2.1% | +1.0% | +1.5% |
| Apr 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $21.05 | $21.06 | +0.0% | +7.6% | +5.7% | +13.5% | +15.2% | +17.4% |
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $21.86 | $21.64 | -1.0% | -3.2% | -3.7% | +3.7% | +1.8% | +9.3% |
| Apr 8 | Evercore ISI | Downgrade | Outperform → In Line | — | $22.50 | $23.13 | +2.8% | -2.8% | -6.0% | -6.4% | +0.7% | -1.1% |
| Mar 9 | RBC Capital | Maintains | Outperform → Outperform | — | $25.34 | $25.00 | -1.3% | +0.6% | -2.2% | -2.8% | -4.2% | -3.8% |
| Feb 20 | JP Morgan | Maintains | Neutral → Neutral | — | $25.23 | $25.05 | -0.7% | +1.3% | -5.8% | -4.6% | -3.3% | -0.5% |
| Feb 20 | Piper Sandler | Maintains | Overweight → Overweight | — | $25.23 | $25.05 | -0.7% | +1.3% | -5.8% | -4.6% | -3.3% | -0.5% |
| Feb 11 | Barclays | Maintains | Overweight → Overweight | — | $27.24 | $27.01 | -0.8% | -4.7% | -9.3% | -8.1% | -9.8% | -6.6% |
| Feb 10 | Mizuho | Maintains | Neutral → Neutral | — | $27.50 | $27.75 | +0.9% | -0.9% | -5.6% | -10.1% | -9.0% | -10.6% |
Recent Filings
8-K · 5.02
!!! Very High
Doximity, Inc. -- 8-K 5.02: Executive Change
Doximity appointed Siddharth Sitaram as interim principal financial officer effective February 3, 2026, signaling potential CFO transition and possible leadership changes at the healthcare platform company.
Apr 17
8-K · 5.02
!!! Very High
Doximity, Inc. -- 8-K 5.02: Executive Change
Doximity (DOCS) appointed Siddharth Sitaram as Chief Accounting Officer effective February 3, 2026, signaling a leadership transition in its financial reporting function.
Feb 5
Data updated apr 25, 2026 5:35am
· Source: massive.com